Catalent provides integrated analytical and manufacturing solutions spanning preclinical development through commercial supply, with specialized expertise in nasal drug products, early-phase liquid pulmonary delivery, and dry powder formulations (spray-dried and micronized/blended). Our inhalation capabilities are supported by robust process development and a proven track record of regulatory excellence, enabling reliable progression from early development to market.